Welltower Stock Extends A 7-Day Losing Streak To A 8.1% Loss
A persistent slide in the healthcare property owner’s stock runs counter to the market, presenting a mixed picture of high growth and premium valuation.
Welltower (WELL) has seen its market value fall by about $15 billion amid a consistent decline. The drop comes as the stock has moved lower for 7 consecutive trading days, wiping out 8.1% of its value. For shareholders, this move has taken the company’s market value down to about $164 billion.
How The Streak Stacks Up Against The S&P 500
Here is how WELL stock stacks up against the S&P 500 over the streak and the periods around it:
- Chime Financial Stock Climbs 21% On A 7-Day Winning Streak
- A 8-Day Winning Streak Has SailPoint Stock Up 22%
- Fortinet Stock Rides A 5-Day Winning Streak To A 12% Gain
- Impinj Stock Rides A 8-Day Winning Streak To A 32% Gain
- InterDigital Stock Climbs 26% On A 8-Day Winning Streak
- Amphenol Stock Climbs 19% On A 5-Day Winning Streak
| Return Period | WELL | S&P 500 |
|---|---|---|
| 1D | -0.7% | 1.8% |
| 7D (Current Streak) | -8.1% | 4.4% |
| 1M (21D) | -0.5% | 2.6% |
| 3M (63D) | 7.0% | 7.4% |
| YTD 2026 | 25.6% | 13.0% |
| 2025 | 49.9% | 16.4% |
| 2024 | 43.1% | 23.3% |
| 2023 | 41.8% | 24.2% |
The stock’s move contrasts with its growth but aligns with its valuation.
This streak is specific to Welltower, not a reflection of the broader market. Over the same 7 trading days the S&P 500 returned +4.4%. The market is not currently crowded with sellers; just 40 S&P 500 stocks are on losing streaks of 3 days or more. The data presents a mixed fundamental case. Revenue over the last twelve months grew 37.8%, far outpacing the S&P 500 median of 7.8%. Yet its operating margin is 5.2%, well below the 18.4% median, and it trades at a price-to-earnings multiple of 106.0, compared to the median of 24.4.
A streak is a signal to re-evaluate, not a command to act.
A string of losses like this is information. It tells you where market momentum and attention are focused, but it is not an instruction. The disciplined response is to use the new information as a prompt to check your own view of the business against the price the market is offering. The fundamental metrics here provide a starting point for that assessment.
If the drop has you weighing an entry, resist buying a falling price alone. Our Buy the Dip screen ranks the marked-down names where growth and cash generation still support a recovery.
Prefer the theme to this single name? A real estate ETF like XLRE owns the whole group. It is still a concentrated bet on that one theme, though, which is exactly the gap the portfolio below closes.
Weakness In One Name Should Be Noise, Not News
For a diversified holder, a streak like this is a data point. For a concentrated one, it is a hole in the plan. The difference is never the stock; it is the portfolio built around it.
Building that portfolio is what the Trefis High Quality (HQ) Portfolio does: roughly 30 businesses with the cash generation and balance-sheet strength to absorb a bad month, selected and rebalanced by rules. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Make the next streak, in either direction, someone else’s drama.